Omalizumab in patients with antihistamine‐resistant CSU
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17368
Abstract: This study from France concerned itself with the biologic drug, omalizumab, as treatment for chronic spontaneous urticaria (CSU). CSU causes troublesome, even debilitating, itchy weals like nettle stings (urticaria), together with swelling of deeper tissues… read more here.
Keywords: omalizumab patients; patients antihistamine; resistant csu; study ... See more keywords